Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 14

Original Research

Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3×3 Crossover Phase II Trial

       
Total article views   HTML views PDF downloads Totals
9,222 Dovepress* 8,575+ 1,494 10,069
PubMed Central* 647 250 897
Totals 9,222 1,744 10,966
*Since 19 September 2019
Total mentioned Facebook Delicious Reddit Twitter Others
20 2 0 0 8 10

View citations on PubMed Central and Google Scholar